Comera Life Sciences Holdings- Warrants (19/05/2027) Operating Income

As of the most recent data (September 2023), CMRAW shows a operating income of $-9.1M. That compares with $-11M in the prior-year period — up 16.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CMRAW's operating income is now $-9.1M (was $-11M) — a 16.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Comera Life Sciences Holdings- Warrants (19/05/2027) is outperforming or lagging.

Tracking CMRAW's operating income over time shows whether Comera Life Sciences Holdings- Warrants (19/05/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $-9.1M That compares with $-11M in the prior-year period — up 16.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Comera Life Sciences Holdings- Warrants (19/05/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-9.1M) with ownership activity and broader fundamentals.